Theseus Pharmaceuticals Q2 EPS $(0.30) Up From $(6.82) YoY

Theseus Pharmaceuticals (NASDAQ:THRX) reported quarterly losses of $(0.30) per share. This is a 95.6 percent increase over losses of $(6.82) per share from the same period last year.

Theseus Pharmaceuticals (NASDAQ:THRX) reported quarterly losses of $(0.30) per share. This is a 95.6 percent increase over losses of $(6.82) per share from the same period last year.

Total
0
Shares
Related Posts
Read More

Forward Air Amends Agreement To Acquire Omni Logistics; Omni Shareholders Will Receive $20M In Cash, Instead Of $150M Initially Agreed, And 35% Of Forward’s Pro Forma Common Equity, As Compared To The 37.7% Contemplated By The Original Agreement

Forward Air Corporation (NASDAQ:FWRD) ("Forward") today announced an agreement with Omni Logistics, LLC ("Omni"), a private company that is majority owned by Ridgemont Equity Partners ("Ridgemont") and EVE Partners, LLC

FWRD